Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
23,771,791
-
Total 13F shares
-
510,346
-
Share change
-
+510,346
-
Total reported value
-
$1,261,065
-
Put/Call ratio
-
1%
-
Price per share
-
$2.44
-
Number of holders
-
20
-
Value change
-
+$1,261,065
-
Number of buys
-
18
Institutional Holders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) as of Q2 2024
As of 30 Jun 2024,
NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
510,346 shares.
The largest 10 holders included
VANGUARD GROUP INC, AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Virtu Financial LLC, STATE STREET CORP, One Wealth Management Investment & Advisory Services, LLC, MORGAN STANLEY, Royal Bank of Canada, and Tower Research Capital LLC (TRC).
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.